Axon Enterprise recorded a sharp intra-day gain of +12.8%, with shares reaching $441.25 in mid-day trading, as investors reacted to a sequence of company-facing developments and fresh confidence in Axon’s AI and counter-drone growth narrative. The price move is among the largest single-session gains the stock has seen recently and comes as the company holds its 2026 Annual Shareholder Meeting today, May 28, at 1:00 PM PDT, immediately after its presentation at TD Cowen’s 2026 TMT Conference on May 27.
Market participants cited rising demand for AI-driven public safety tools and counter-drone solutions as central to the renewed optimism. Axon’s Dedrone unit reported first-quarter revenue growth of 300%, and investors have been attentive to the potential for those product lines to drive an extended expansion phase for the company.
The rally also appears to reflect a delayed, but forceful, market digestion of Axon’s Q1 2026 results, which were released on May 6. Axon reported Q1 2026 revenue of $807 million, up 34% year over year and beating analyst expectations by more than 3%. The company disclosed AI-related product revenue growth of more than 7x year over year and Dedrone counter-drone bookings rising by approximately 500%. Management subsequently raised full-year revenue growth guidance to a range of 30%–32%.
CEO Patrick Smith noted that clients increasingly view AI as essential to improving productivity and operational effectiveness. Management highlighted stronger adoption for newer offerings such as Axon Vision and Guardian, signaling that product uptake is contributing to the revenue momentum.
Analyst coverage remains favorable. According to 20 analysts, the average rating for AXON shares is "Buy." Market observers also described today’s price action in part as a mean-reversion response following a significant prior selloff: Axon shares had been down roughly 31% year-to-date and about 48% over the past year before the rebound.
On the institutional ownership front, Legal & General Group increased its holdings in Axon by 1.3% in the fourth quarter, as noted in its most recent SEC filing, indicating continued interest from some large investors.
The broader equity market provided a modestly positive backdrop but did not drive the magnitude of AXON’s move. The S&P 500 rose +0.5%, the Dow Jones Industrial Average was up +0.1%, and the NASDAQ gained +0.7%, underscoring that Axon’s outsized gain was primarily the result of company-specific catalysts rather than broad market tailwinds.
Axon’s first-quarter performance included several notable metrics that investors pointed to when reassessing the stock: 34% overall revenue growth, more than 700% growth in AI-related products, in excess of 300% growth in counter-drone revenue, net revenue retention at 125%, and future contracted bookings of $14.3 billion. Management’s reaffirmed guidance of 30%–32% revenue growth for the year contributes to a multi-year visibility thesis cited by supporters.
Taken together, the timing of the Annual Meeting, the TD Cowen conference presentation, and the persistence of strong early-year fundamental indicators helped reprice the stock higher in a single session as investors revisited Axon’s growth trajectory.
What to watch next
- Investor reaction during and after the Annual Shareholder Meeting and the TD Cowen presentation could influence near-term momentum.
- Whether the elevated Q1 growth rates in AI products and Dedrone translate into sustained revenue expansion across subsequent quarters.